Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections.
暂无分享,去创建一个
M. Nishiyama | K. Okumura | S. Kanada | C. Nishiyama | N. Nakano | H. Ushio | N. Shimokawa | Y. Niwa | H. Ogawa
[1] F. Liew,et al. IL-12, but Not IL-18, Is Critical to Neutrophil Activation and Resistance to Polymicrobial Sepsis Induced by Cecal Ligation and Puncture1 , 2006, The Journal of Immunology.
[2] M. Nishiyama,et al. FOG-1 represses GATA-1-dependent FcϵRI β-chain transcription: transcriptional mechanism of mast-cell-specific gene expression in mice , 2006 .
[3] J. Rivera. Adaptors discriminate mast-cell cytokine production from eicosanoid production and degranulation. , 2006, Trends in immunology.
[4] C. Hunter. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions , 2005, Nature Reviews Immunology.
[5] R. de Waal Malefyt,et al. IL‐12 and IL‐23: master regulators of innate and adaptive immunity , 2004, Immunological reviews.
[6] A. Gottlieb,et al. A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. , 2004, The Journal of investigative dermatology.
[7] R. Kastelein,et al. IL-23 Provides a Limited Mechanism of Resistance to Acute Toxoplasmosis in the Absence of IL-121 , 2004, The Journal of Immunology.
[8] M. Nishiyama,et al. Functional analysis of PU.1 domains in monocyte‐specific gene regulation , 2004, FEBS letters.
[9] C. Hölscher. The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases , 2004, Medical Microbiology and Immunology.
[10] M. Nishiyama,et al. Overproduction of PU.1 in mast cell progenitors: its effect on monocyte- and mast cell-specific gene expression. , 2004, Biochemical and biophysical research communications.
[11] S. Plevy,et al. Activation of the Murine Interleukin-12 p40 Promoter by Functional Interactions between NFAT and ICSBP* , 2003, Journal of Biological Chemistry.
[12] Y. Okayama,et al. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI. , 2003, Blood.
[13] R. Kastelein,et al. Novel IL-12 family members shed light on the orchestration of Th1 responses , 2003, Trends in Immunology.
[14] M. Scott,et al. Natural Killer Cells Participate in Bacterial Clearance During Septic Peritonitis Through Interactions with Macrophages , 2003, Shock.
[15] G. Trinchieri,et al. Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.
[16] A. Sher,et al. ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro. , 2003, Blood.
[17] M. Nishiyama,et al. Regulation of Cell Type-Specific Mouse FcεRI β-Chain Gene Expression by GATA-1 Via Four GATA Motifs in the Promoter1 , 2003, The Journal of Immunology.
[18] I. Wang,et al. IRF‐8/ICSBP and IRF‐1 cooperatively stimulate mouse IL‐12 promoter activity in macrophages , 2002, FEBS letters.
[19] S. Akira,et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. , 2002, The Journal of clinical investigation.
[20] M. Nishiyama,et al. Regulation of Human FcεRI α-Chain Gene Expression by Multiple Transcription Factors , 2002, The Journal of Immunology.
[21] M. Arock,et al. The role of mast cells in host defense and their subversion by bacterial pathogens. , 2002, Trends in immunology.
[22] B. Echtenacher,et al. Differences in Innate Defense Mechanisms in Endotoxemia and Polymicrobial Septic Peritonitis , 2001, Infection and Immunity.
[23] S. Schwartzbach,et al. Deletional Analysis of the Murine IL-12 p35 Promoter Comparing IFN-γ and Lipopolysaccharide Stimulation1 , 2001, The Journal of Immunology.
[24] A. Lentsch,et al. STAT4 Is Required for Antibacterial Defense but Enhances Mortality during Polymicrobial Sepsis , 2001, Clinical Diagnostic Laboratory Immunology.
[25] E. Farber,et al. Mast cell density and IL‐8 expression in nonlesional and lesional psoriatic skin , 2001, International journal of dermatology.
[26] A. Nakao,et al. Protective Roles of Mast Cells Against Enterobacterial Infection Are Mediated by Toll-Like Receptor 41 , 2001, The Journal of Immunology.
[27] J Wagner,et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.
[28] P. Scott,et al. IL-12 Is Required to Maintain a Th1 Response During Leishmania major Infection1 , 2000, The Journal of Immunology.
[29] A. Sher,et al. Cutting Edge: IL-12 Is Required for the Maintenance of IFN-γ Production in T Cells Mediating Chronic Resistance to the Intracellular Pathogen, Toxoplasma gondii , 2000, The Journal of Immunology.
[30] G. Trinchieri,et al. An IFN-γ-Inducible Transcription Factor, IFN Consensus Sequence Binding Protein (ICSBP), Stimulates IL-12 p40 Expression in Macrophages , 2000, The Journal of Immunology.
[31] S. Abraham,et al. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis , 2000, Journal of leukocyte biology.
[32] T. Irimura,et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. , 1999, The Journal of clinical investigation.
[33] M. Atchison,et al. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages. , 1999, Journal of immunology.
[34] B. Torbett,et al. Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression. , 1999, Journal of immunology.
[35] C. Ra,et al. The transcription factors Elf-1 and GATA-1 bind to cell-specific enhancer elements of human high-affinity IgE receptor alpha-chain gene. , 1999, Journal of immunology.
[36] S. Holgate,et al. Immunopathology and human mast cell cytokines. , 1999, Critical reviews in oncology/hematology.
[37] R. Strieter,et al. Multiple roles for IL-12 in a model of acute septic peritonitis. , 1999, Journal of immunology.
[38] G. Kollias,et al. The c-kit Ligand, Stem Cell Factor, Can Enhance Innate Immunity Through Effects on Mast Cells , 1998, The Journal of experimental medicine.
[39] A. Sher,et al. Interferon Consensus Sequence Binding Protein–deficient Mice Display Impaired Resistance to Intracellular Infection Due to a Primary Defect in Interleukin 12 p40 Induction , 1997, The Journal of experimental medicine.
[40] N. Giese,et al. Interferon (IFN) Consensus Sequence-binding Protein, a Transcription Factor of the IFN Regulatory Factor Family, Regulates Immune Responses In Vivo through Control of Interleukin 12 Expression , 1997, The Journal of experimental medicine.
[41] I. Orme,et al. Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.
[42] G. Ciliberto,et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. , 1997, Immunity.
[43] G. Trinchieri,et al. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). , 1997, Current opinion in immunology.
[44] J. Waring,et al. Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene , 1996, Cell.
[45] K. Croitoru,et al. Rat peritoneal mast cells produce IFN-gamma following IL-12 treatment but not in response to IgE-mediated activation. , 1996, Journal of immunology.
[46] J. Lederer,et al. Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. , 1996, Surgery.
[47] B. Echtenacher,et al. Critical protective role of mast cells in a model of acute septic peritonitis , 1996, Nature.
[48] S. Galli,et al. The two faces of the mast cell , 1996, Nature.
[49] S. Abraham,et al. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.
[50] A. Enk,et al. IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. , 1995, Journal of immunology.
[51] K. Murphy,et al. Regulation of interleukin 12 p40 expression through an NF-kappa B half-site , 1995, Molecular and cellular biology.
[52] P. Puccetti,et al. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. , 1994, Journal of immunology.
[53] J. Weis,et al. Preferential expression of interleukin‐12 or interleukin‐4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin‐3 , 1994, European journal of immunology.
[54] G. Trinchieri,et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells , 1993, The Journal of experimental medicine.
[55] C. Hsieh,et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.
[56] Giorgio,et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells , 1992, The Journal of experimental medicine.
[57] P. Familletti,et al. Cloning and expression of murine IL-12. , 1992, Journal of immunology.
[58] P. Familletti,et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[59] R. Hewick,et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. , 1991, Journal of immunology.
[60] B. Echtenacher,et al. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. , 1990, Journal of immunology.
[61] E. Appella,et al. An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[62] G. Trinchieri,et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes , 1989, Journal of Experimental Medicine.
[63] S. Galli,et al. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell- deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells , 1985, The Journal of experimental medicine.
[64] K. Austen,et al. Immunologic Release of β-Hexosaminidase and β-Glucuronidase from Purified Rat Serosal Mast Cells , 1979, Journal of Immunology.
[65] M. Nishiyama,et al. FOG-1 represses GATA-1-dependent FcepsilonRI beta-chain transcription: transcriptional mechanism of mast-cell-specific gene expression in mice. , 2006, Blood.
[66] 伊藤 友章. Mast cells acquire monocyte-specific gene expression and monocyte-like morphology by overproduction of PU.1 , 2005 .
[67] M. Nishiyama,et al. Regulation of cell type-specific mouse Fc epsilon RI beta-chain gene expression by GATA-1 via four GATA motifs in the promoter. , 2003, Journal of immunology.
[68] K. Ozato,et al. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[69] K. Austen,et al. Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells. , 1979, Journal of immunology.